Weizhong X. Wu

Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.

Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.

Journal: Journal of pharmaceutical analysis

Published: March 10, 2025

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma.

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: February 19, 2024

Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.

Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.

Journal: Journal of medical virology

Published: December 19, 2023

Aptamers: Promising Reagents in Biomedicine Application.

Aptamers: Promising Reagents in Biomedicine Application.

Journal: Advanced biology

Published: December 05, 2023

miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway.

miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway.

Journal: Journal of hepatocellular carcinoma

Published: August 01, 2023

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.

Journal: Biomarker research

Published: July 26, 2023

GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.

GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.

Journal: Cell biology and toxicology

Published: April 18, 2023

Correction: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.

Correction: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.

Journal: Signal transduction and targeted therapy

Published: December 20, 2022

Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum.

Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum.

Journal: Theranostics

Published: June 06, 2022

Pathological diagnosis and clinical pathological significance of metaplastic changes in gastroenterological mucosa

Pathological diagnosis and clinical pathological significance of metaplastic changes in gastroenterological mucosa

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: October 08, 2021

CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.

CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.

Journal: Cell death & disease

Published: October 07, 2021

An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.

An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.

Journal: Combinatorial chemistry & high throughput screening

Published: August 24, 2021

Showing 1-12 of 48

Last Updated: 09/26/2026